US Bancorp DE Takes Position in Nutriband Inc. $NTRB

US Bancorp DE purchased a new stake in shares of Nutriband Inc. (NASDAQ:NTRB) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,798 shares of the company’s stock, valued at approximately $29,000.

Separately, Geode Capital Management LLC increased its holdings in shares of Nutriband by 7.5% in the 4th quarter. Geode Capital Management LLC now owns 62,435 shares of the company’s stock worth $294,000 after purchasing an additional 4,372 shares in the last quarter. Institutional investors own 19.70% of the company’s stock.

Nutriband Stock Performance

Shares of NASDAQ:NTRB opened at $6.22 on Thursday. The company has a market cap of $69.35 million, a P/E ratio of -6.91 and a beta of 1.13. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.71 and a quick ratio of 3.48. Nutriband Inc. has a 1 year low of $3.72 and a 1 year high of $11.78. The stock’s fifty day moving average price is $7.74 and its 200-day moving average price is $6.81.

Nutriband (NASDAQ:NTRB) last released its quarterly earnings data on Friday, May 30th. The company reported ($0.12) EPS for the quarter, topping the consensus estimate of ($0.13) by $0.01. The company had revenue of $0.67 million during the quarter, compared to the consensus estimate of $0.71 million. Nutriband had a negative return on equity of 68.25% and a negative net margin of 415.93%. Sell-side analysts expect that Nutriband Inc. will post -0.6 earnings per share for the current year.

Nutriband Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.